Atlas Trials

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Clinical trial NCT03751293 · UNKNOWN

Trial details

NCT number
NCT03751293
Sponsor
Hebei Yanda Ludaopei Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed or Refractory Multiple Myeloma
Start date
2019-01-08
Primary completion
2019-10-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.